Loading...
Keywords
Last Name
Institution
 Back to Details

Connection

Rebecca Rentea to Enterocolitis

This is a "connection" page, showing publications Rebecca Rentea has written about Enterocolitis.

 
Connection Strength
  
 
 
6.732
  
  1. Bokova E, Prasade N, Lewis WE, Feira CN, Lim IIP, Oyetunji TA, Rentea RM. Evaluation of Post-neonatal Intensive Care Unit Home Irrigations Prior to Pull-through: Implications for Hirschsprung Disease Management. J Pediatr Surg. 2024 Jul; 59(7):1245-1249.
    View in: PubMed
    Score: 0.902
  2. Svetanoff WJ, Lim-Beutal IIP, Wood RJ, Levitt MA, Rentea RM. The utilization of botulinum toxin for Hirschsprung disease. Semin Pediatr Surg. 2022 Apr; 31(2):151161.
    View in: PubMed
    Score: 0.789
  3. Svetanoff WJ, Lopez JJ, Briggs KB, Fraser JA, Fraser JD, Oyetunji TA, Peter SDS, Rentea RM. Management of Hirschsprung associated enterocolitis-How different are practice strategies? An international pediatric endosurgery group (IPEG) survey. J Pediatr Surg. 2022 Jun; 57(6):1119-1126.
    View in: PubMed
    Score: 0.781
  4. Svetanoff WJ, Briggs K, Fraser JA, Lopez J, Fraser JD, Juang D, Aguayo P, Hendrickson RJ, Snyder CL, Oyetunji TA, St Peter SD, Rentea RM. Outpatient Botulinum Injections for Early Obstructive Symptoms in Patients with Hirschsprung Disease. J Surg Res. 2022 01; 269:201-206.
    View in: PubMed
    Score: 0.761
  5. Svetanoff WJ, Lopez J, Aguayo P, Hendrickson RJ, Oyetunji TA, Rentea RM. The impact of botulinum injection for hospitalized children with Hirschsprung-associated enterocolitis. Pediatr Surg Int. 2021 Oct; 37(10):1467-1472.
    View in: PubMed
    Score: 0.752
  6. Svetanoff WJ, Rentea RM. Post-operative enterocolitis in Hirschsprung's disease: response to a Letter to the Editor. Pediatr Surg Int. 2021 04; 37(4):527-528.
    View in: PubMed
    Score: 0.729
  7. Rentea RM, Noel-MacDonnell JR, Bucher BT, Dorman MR, Lautz TB, Pruitt LCC, Oyetunji TA. Impact of Botulinum Toxin on Hirschsprung-Associated Enterocolitis After Primary Pull-Through. J Surg Res. 2021 05; 261:95-104.
    View in: PubMed
    Score: 0.724
  8. Svetanoff WJ, Dekonenko C, Osuchukwu O, Oyetunji TA, Aguayo P, Fraser JD, Juang D, Snyder CL, Hendrickson R, Peter SS, Rentea RM. Inpatient management of Hirschsprung's associated enterocolitis treatment: the benefits of standardized care. Pediatr Surg Int. 2020 Dec; 36(12):1413-1421.
    View in: PubMed
    Score: 0.710
  9. Sutthatarn P, Lapidus-Krol E, Smith C, Halaweish I, Rialon K, Ralls MW, Rentea RM, Madonna MB, Haddock C, Rocca AM, Gosain A, Frischer J, Piper H, Goldstein AM, Saadai P, Durham MM, Dickie B, Jafri M, Langer JC. Hirschsprung-associated inflammatory bowel disease: A multicenter study from the APSA Hirschsprung disease interest group. J Pediatr Surg. 2023 May; 58(5):856-861.
    View in: PubMed
    Score: 0.208
  10. Ahmad H, Rentea RM, Knaus ME, Wilbur JG, Halaweish I, Langer JC, Levitt MA, Wood RJ. Routine botulinum toxin injection one month after a Swenson pull-through does not change the incidence of Hirschsprung associated enterocolitis. J Pediatr Surg. 2022 Aug; 57(8):1453-1457.
    View in: PubMed
    Score: 0.193
  11. Kawaguchi AL, Guner YS, S?mme S, Quesenberry AC, Arthur LG, Sola JE, Downard CD, Rentea RM, Valusek PA, Smith CA, Slidell MB, Ricca RL, Dasgupta R, Renaud E, Miniati D, McAteer J, Beres AL, Grabowski J, Peter SDS, Gosain A. Management and outcomes for long-segment Hirschsprung disease: A systematic review from the APSA Outcomes and Evidence Based Practice Committee. J Pediatr Surg. 2021 Sep; 56(9):1513-1523.
    View in: PubMed
    Score: 0.184
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.